Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells.
Olga E ChepikovaDmitry MalinElena StrekalovaElena V LukashevaAndrey A ZamyatninVincent L CrynsPublished in: Breast cancer research and treatment (2020)
LO exposes a redox vulnerability of TNBC cells to TXNRD inhibition by rendering tumor cells dependent on the thioredoxin antioxidant pathway for survival.